Skip to main content
Back
Watch Compare

Harvard Apparatus Regenerative Technology, Inc.

Data quality: 100%
HRGN
OTC Manufacturing Measuring & Analyzing Instruments
$1.57
▼ $0.11 (-6.26%)
Mkt Cap: 27.64 M
Price
$1.57
Mkt Cap
27.64 M
Day Range
$1.48 — $1.48
52-Week Range
$0.94 — $2.22
Volume
2
Open $1.48
50D / 200D Avg
$1.73
8.94% below
50D / 200D Avg
$1.74
9.47% below

Quick Summary

Key Takeaways

Negative free cash flow of -3.83 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)63.72%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-593.43%
Below sector avg (-51.02%)
ROIC-424.13%
Net Margin-975.71%
Op. Margin-982.24%

Safety

Debt / Equity
N/A
Current Ratio1.86
Interest Coverage-864.38

Valuation

PE (TTM)
-4.02
Below sector avg (-1.98)
P/B Ratio17.78
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -4.0 -2.0
P/B 17.8 5.1
ROE % -593.4 -51.0
Net Margin % -975.7 -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 63.72% Revenue Growth (3Y) 161.44%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 704,000.0 Net Income (TTM) -6.87 M
ROE -593.43% ROA -293.36%
Gross Margin N/A Operating Margin -982.24%
Net Margin -975.71% Free Cash Flow (TTM) -3.83 M
ROIC -424.13% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.86
Interest Coverage -864.38 Asset Turnover 0.30
Working Capital 751,000 Tangible Book Value 1.55 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.02 Forward P/E N/A
P/B Ratio 17.78 P/S Ratio 39.26
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -13.85%
Market Cap 27.64 M Enterprise Value 26.32 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.04
FCF / Share -0.22 OCF / Share -0.22
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 55.73%
SBC-Adj. FCF -5.91 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 704,000.0 430,000.0 103,000.0 — 0.0
Net Income -6.87 M -7.73 M -8.95 M -6.07 M -7.98 M
EPS (Diluted) — — -0.67 — -0.79
Gross Profit — — — — —
Operating Income -6.92 M -7.73 M -8.99 M -6.15 M -8.64 M
EBITDA — — — — —
R&D Expenses 2.65 M 2.31 M 3.06 M 1.74 M 1.59 M
SG&A Expenses — — — 4.41 M 7.04 M
D&A — — — — —
Interest Expense 8,000.0 38,000.0 14,000.0 — —
Income Tax 0.0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2.68 M 4.44 M 2.61 M 2.40 M 1.87 M
Total Liabilities 1.62 M 1.22 M 968,000.0 1.41 M 4.90 M
Shareholders' Equity 1.06 M 3.22 M 1.65 M -3.19 M -3.03 M
Total Debt — — — — —
Cash & Equivalents 1.35 M 2.49 M 432,000.0 — —
Current Assets 1.83 M 3.23 M 783,000.0 1.59 M 1.59 M
Current Liabilities 1.53 M 1.02 M 968,000.0 1.36 M 4.84 M